 | • レポートコード：MRC308GR09497 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の筋骨格系疾患治療の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の筋骨格系疾患治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 筋骨格系疾患治療の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
筋骨格系疾患治療市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・経口薬、筋肉注射薬、その他
用途別セグメント
・クリニック、病院、その他
主要な市場プレーヤー
・Pfizer Inc.、Abbvie Inc.、Novartis AG、Amgen Inc.、Boehringer Ingelheim International GmbH.、Merck & Co Inc.、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceuticals Industries Ltd.、AstraZeneca、Ampio Pharmaceuticals Inc.、Eli Lilly and Company、Novartis International AG、Sanofi S.A.
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、筋骨格系疾患治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な筋骨格系疾患治療メーカーの企業概要、2019年～2022年までの筋骨格系疾患治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な筋骨格系疾患治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別筋骨格系疾患治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの筋骨格系疾患治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での筋骨格系疾患治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および筋骨格系疾患治療の産業チェーンを掲載しています。
・第14、15章では、筋骨格系疾患治療の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 筋骨格系疾患治療の概要
– 種類別分析（2018年vs2022年vs2029年）：経口薬、筋肉注射薬、その他
– 用途別分析（2018年vs2022年vs2029年）：クリニック、病院、その他
– 世界の筋骨格系疾患治療市場規模・予測
– 世界の筋骨格系疾患治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Pfizer Inc.、Abbvie Inc.、Novartis AG、Amgen Inc.、Boehringer Ingelheim International GmbH.、Merck & Co Inc.、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceuticals Industries Ltd.、AstraZeneca、Ampio Pharmaceuticals Inc.、Eli Lilly and Company、Novartis International AG、Sanofi S.A.
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：経口薬、筋肉注射薬、その他
・用途別分析2018年-2029年：クリニック、病院、その他
・筋骨格系疾患治療の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・筋骨格系疾患治療のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・筋骨格系疾患治療のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・筋骨格系疾患治療の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・筋骨格系疾患治療の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Musculoskeletal Pain Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Musculoskeletal Pain Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral Drugs
1.3.3 Intramuscular Injection
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Musculoskeletal Pain Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Clinic
1.4.3 Hospital
1.4.4 Others
1.5 Global Musculoskeletal Pain Treatment Market Size & Forecast
1.5.1 Global Musculoskeletal Pain Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Musculoskeletal Pain Treatment Sales Quantity (2018-2029)
1.5.3 Global Musculoskeletal Pain Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Musculoskeletal Pain Treatment Product and Services
2.1.4 Pfizer Inc. Musculoskeletal Pain Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Inc. Recent Developments/Updates
2.2 Abbvie Inc.
2.2.1 Abbvie Inc. Details
2.2.2 Abbvie Inc. Major Business
2.2.3 Abbvie Inc. Musculoskeletal Pain Treatment Product and Services
2.2.4 Abbvie Inc. Musculoskeletal Pain Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbvie Inc. Recent Developments/Updates
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Musculoskeletal Pain Treatment Product and Services
2.3.4 Novartis AG Musculoskeletal Pain Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis AG Recent Developments/Updates
2.4 Amgen Inc.
2.4.1 Amgen Inc. Details
2.4.2 Amgen Inc. Major Business
2.4.3 Amgen Inc. Musculoskeletal Pain Treatment Product and Services
2.4.4 Amgen Inc. Musculoskeletal Pain Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Amgen Inc. Recent Developments/Updates
2.5 Boehringer Ingelheim International GmbH.
2.5.1 Boehringer Ingelheim International GmbH. Details
2.5.2 Boehringer Ingelheim International GmbH. Major Business
2.5.3 Boehringer Ingelheim International GmbH. Musculoskeletal Pain Treatment Product and Services
2.5.4 Boehringer Ingelheim International GmbH. Musculoskeletal Pain Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boehringer Ingelheim International GmbH. Recent Developments/Updates
2.6 Merck & Co Inc.
2.6.1 Merck & Co Inc. Details
2.6.2 Merck & Co Inc. Major Business
2.6.3 Merck & Co Inc. Musculoskeletal Pain Treatment Product and Services
2.6.4 Merck & Co Inc. Musculoskeletal Pain Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck & Co Inc. Recent Developments/Updates
2.7 Sun Pharmaceutical Industries Ltd.
2.7.1 Sun Pharmaceutical Industries Ltd. Details
2.7.2 Sun Pharmaceutical Industries Ltd. Major Business
2.7.3 Sun Pharmaceutical Industries Ltd. Musculoskeletal Pain Treatment Product and Services
2.7.4 Sun Pharmaceutical Industries Ltd. Musculoskeletal Pain Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
2.8 Teva Pharmaceuticals Industries Ltd.
2.8.1 Teva Pharmaceuticals Industries Ltd. Details
2.8.2 Teva Pharmaceuticals Industries Ltd. Major Business
2.8.3 Teva Pharmaceuticals Industries Ltd. Musculoskeletal Pain Treatment Product and Services
2.8.4 Teva Pharmaceuticals Industries Ltd. Musculoskeletal Pain Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Teva Pharmaceuticals Industries Ltd. Recent Developments/Updates
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Musculoskeletal Pain Treatment Product and Services
2.9.4 AstraZeneca Musculoskeletal Pain Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 AstraZeneca Recent Developments/Updates
2.10 Ampio Pharmaceuticals Inc.
2.10.1 Ampio Pharmaceuticals Inc. Details
2.10.2 Ampio Pharmaceuticals Inc. Major Business
2.10.3 Ampio Pharmaceuticals Inc. Musculoskeletal Pain Treatment Product and Services
2.10.4 Ampio Pharmaceuticals Inc. Musculoskeletal Pain Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Ampio Pharmaceuticals Inc. Recent Developments/Updates
2.11 Eli Lilly and Company
2.11.1 Eli Lilly and Company Details
2.11.2 Eli Lilly and Company Major Business
2.11.3 Eli Lilly and Company Musculoskeletal Pain Treatment Product and Services
2.11.4 Eli Lilly and Company Musculoskeletal Pain Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Eli Lilly and Company Recent Developments/Updates
2.12 Novartis International AG
2.12.1 Novartis International AG Details
2.12.2 Novartis International AG Major Business
2.12.3 Novartis International AG Musculoskeletal Pain Treatment Product and Services
2.12.4 Novartis International AG Musculoskeletal Pain Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Novartis International AG Recent Developments/Updates
2.13 Sanofi S.A.
2.13.1 Sanofi S.A. Details
2.13.2 Sanofi S.A. Major Business
2.13.3 Sanofi S.A. Musculoskeletal Pain Treatment Product and Services
2.13.4 Sanofi S.A. Musculoskeletal Pain Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Sanofi S.A. Recent Developments/Updates
3 Competitive Environment: Musculoskeletal Pain Treatment by Manufacturer
3.1 Global Musculoskeletal Pain Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Musculoskeletal Pain Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Musculoskeletal Pain Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Musculoskeletal Pain Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Musculoskeletal Pain Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Musculoskeletal Pain Treatment Manufacturer Market Share in 2022
3.5 Musculoskeletal Pain Treatment Market: Overall Company Footprint Analysis
3.5.1 Musculoskeletal Pain Treatment Market: Region Footprint
3.5.2 Musculoskeletal Pain Treatment Market: Company Product Type Footprint
3.5.3 Musculoskeletal Pain Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Musculoskeletal Pain Treatment Market Size by Region
4.1.1 Global Musculoskeletal Pain Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Musculoskeletal Pain Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Musculoskeletal Pain Treatment Average Price by Region (2018-2029)
4.2 North America Musculoskeletal Pain Treatment Consumption Value (2018-2029)
4.3 Europe Musculoskeletal Pain Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Musculoskeletal Pain Treatment Consumption Value (2018-2029)
4.5 South America Musculoskeletal Pain Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Musculoskeletal Pain Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Musculoskeletal Pain Treatment Sales Quantity by Type (2018-2029)
5.2 Global Musculoskeletal Pain Treatment Consumption Value by Type (2018-2029)
5.3 Global Musculoskeletal Pain Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Musculoskeletal Pain Treatment Sales Quantity by Application (2018-2029)
6.2 Global Musculoskeletal Pain Treatment Consumption Value by Application (2018-2029)
6.3 Global Musculoskeletal Pain Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Musculoskeletal Pain Treatment Sales Quantity by Type (2018-2029)
7.2 North America Musculoskeletal Pain Treatment Sales Quantity by Application (2018-2029)
7.3 North America Musculoskeletal Pain Treatment Market Size by Country
7.3.1 North America Musculoskeletal Pain Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Musculoskeletal Pain Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Musculoskeletal Pain Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Musculoskeletal Pain Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Musculoskeletal Pain Treatment Market Size by Country
8.3.1 Europe Musculoskeletal Pain Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Musculoskeletal Pain Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Musculoskeletal Pain Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Musculoskeletal Pain Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Musculoskeletal Pain Treatment Market Size by Region
9.3.1 Asia-Pacific Musculoskeletal Pain Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Musculoskeletal Pain Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Musculoskeletal Pain Treatment Sales Quantity by Type (2018-2029)
10.2 South America Musculoskeletal Pain Treatment Sales Quantity by Application (2018-2029)
10.3 South America Musculoskeletal Pain Treatment Market Size by Country
10.3.1 South America Musculoskeletal Pain Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Musculoskeletal Pain Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Musculoskeletal Pain Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Musculoskeletal Pain Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Musculoskeletal Pain Treatment Market Size by Country
11.3.1 Middle East & Africa Musculoskeletal Pain Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Musculoskeletal Pain Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Musculoskeletal Pain Treatment Market Drivers
12.2 Musculoskeletal Pain Treatment Market Restraints
12.3 Musculoskeletal Pain Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Musculoskeletal Pain Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Musculoskeletal Pain Treatment
13.3 Musculoskeletal Pain Treatment Production Process
13.4 Musculoskeletal Pain Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Musculoskeletal Pain Treatment Typical Distributors
14.3 Musculoskeletal Pain Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Musculoskeletal Pain Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Musculoskeletal Pain Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Musculoskeletal Pain Treatment Product and Services
Table 6. Pfizer Inc. Musculoskeletal Pain Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Inc. Recent Developments/Updates
Table 8. Abbvie Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Abbvie Inc. Major Business
Table 10. Abbvie Inc. Musculoskeletal Pain Treatment Product and Services
Table 11. Abbvie Inc. Musculoskeletal Pain Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Abbvie Inc. Recent Developments/Updates
Table 13. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 14. Novartis AG Major Business
Table 15. Novartis AG Musculoskeletal Pain Treatment Product and Services
Table 16. Novartis AG Musculoskeletal Pain Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis AG Recent Developments/Updates
Table 18. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Amgen Inc. Major Business
Table 20. Amgen Inc. Musculoskeletal Pain Treatment Product and Services
Table 21. Amgen Inc. Musculoskeletal Pain Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Amgen Inc. Recent Developments/Updates
Table 23. Boehringer Ingelheim International GmbH. Basic Information, Manufacturing Base and Competitors
Table 24. Boehringer Ingelheim International GmbH. Major Business
Table 25. Boehringer Ingelheim International GmbH. Musculoskeletal Pain Treatment Product and Services
Table 26. Boehringer Ingelheim International GmbH. Musculoskeletal Pain Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Boehringer Ingelheim International GmbH. Recent Developments/Updates
Table 28. Merck & Co Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Merck & Co Inc. Major Business
Table 30. Merck & Co Inc. Musculoskeletal Pain Treatment Product and Services
Table 31. Merck & Co Inc. Musculoskeletal Pain Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Merck & Co Inc. Recent Developments/Updates
Table 33. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Sun Pharmaceutical Industries Ltd. Major Business
Table 35. Sun Pharmaceutical Industries Ltd. Musculoskeletal Pain Treatment Product and Services
Table 36. Sun Pharmaceutical Industries Ltd. Musculoskeletal Pain Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 38. Teva Pharmaceuticals Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. Teva Pharmaceuticals Industries Ltd. Major Business
Table 40. Teva Pharmaceuticals Industries Ltd. Musculoskeletal Pain Treatment Product and Services
Table 41. Teva Pharmaceuticals Industries Ltd. Musculoskeletal Pain Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Teva Pharmaceuticals Industries Ltd. Recent Developments/Updates
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Musculoskeletal Pain Treatment Product and Services
Table 46. AstraZeneca Musculoskeletal Pain Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. AstraZeneca Recent Developments/Updates
Table 48. Ampio Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Ampio Pharmaceuticals Inc. Major Business
Table 50. Ampio Pharmaceuticals Inc. Musculoskeletal Pain Treatment Product and Services
Table 51. Ampio Pharmaceuticals Inc. Musculoskeletal Pain Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Ampio Pharmaceuticals Inc. Recent Developments/Updates
Table 53. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 54. Eli Lilly and Company Major Business
Table 55. Eli Lilly and Company Musculoskeletal Pain Treatment Product and Services
Table 56. Eli Lilly and Company Musculoskeletal Pain Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Eli Lilly and Company Recent Developments/Updates
Table 58. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 59. Novartis International AG Major Business
Table 60. Novartis International AG Musculoskeletal Pain Treatment Product and Services
Table 61. Novartis International AG Musculoskeletal Pain Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Novartis International AG Recent Developments/Updates
Table 63. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 64. Sanofi S.A. Major Business
Table 65. Sanofi S.A. Musculoskeletal Pain Treatment Product and Services
Table 66. Sanofi S.A. Musculoskeletal Pain Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Sanofi S.A. Recent Developments/Updates
Table 68. Global Musculoskeletal Pain Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global Musculoskeletal Pain Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Musculoskeletal Pain Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in Musculoskeletal Pain Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Musculoskeletal Pain Treatment Production Site of Key Manufacturer
Table 73. Musculoskeletal Pain Treatment Market: Company Product Type Footprint
Table 74. Musculoskeletal Pain Treatment Market: Company Product Application Footprint
Table 75. Musculoskeletal Pain Treatment New Market Entrants and Barriers to Market Entry
Table 76. Musculoskeletal Pain Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Musculoskeletal Pain Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global Musculoskeletal Pain Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global Musculoskeletal Pain Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Musculoskeletal Pain Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Musculoskeletal Pain Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global Musculoskeletal Pain Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global Musculoskeletal Pain Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global Musculoskeletal Pain Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global Musculoskeletal Pain Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Musculoskeletal Pain Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Musculoskeletal Pain Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global Musculoskeletal Pain Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global Musculoskeletal Pain Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global Musculoskeletal Pain Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global Musculoskeletal Pain Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Musculoskeletal Pain Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Musculoskeletal Pain Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global Musculoskeletal Pain Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America Musculoskeletal Pain Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America Musculoskeletal Pain Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America Musculoskeletal Pain Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America Musculoskeletal Pain Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America Musculoskeletal Pain Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America Musculoskeletal Pain Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America Musculoskeletal Pain Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Musculoskeletal Pain Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Musculoskeletal Pain Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe Musculoskeletal Pain Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe Musculoskeletal Pain Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe Musculoskeletal Pain Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe Musculoskeletal Pain Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe Musculoskeletal Pain Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe Musculoskeletal Pain Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Musculoskeletal Pain Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Musculoskeletal Pain Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific Musculoskeletal Pain Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific Musculoskeletal Pain Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific Musculoskeletal Pain Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific Musculoskeletal Pain Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific Musculoskeletal Pain Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific Musculoskeletal Pain Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Musculoskeletal Pain Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Musculoskeletal Pain Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America Musculoskeletal Pain Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America Musculoskeletal Pain Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America Musculoskeletal Pain Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America Musculoskeletal Pain Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America Musculoskeletal Pain Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America Musculoskeletal Pain Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Musculoskeletal Pain Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Musculoskeletal Pain Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa Musculoskeletal Pain Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa Musculoskeletal Pain Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa Musculoskeletal Pain Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa Musculoskeletal Pain Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa Musculoskeletal Pain Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa Musculoskeletal Pain Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Musculoskeletal Pain Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Musculoskeletal Pain Treatment Raw Material
Table 136. Key Manufacturers of Musculoskeletal Pain Treatment Raw Materials
Table 137. Musculoskeletal Pain Treatment Typical Distributors
Table 138. Musculoskeletal Pain Treatment Typical Customers
List of Figures
Figure 1. Musculoskeletal Pain Treatment Picture
Figure 2. Global Musculoskeletal Pain Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Musculoskeletal Pain Treatment Consumption Value Market Share by Type in 2022
Figure 4. Oral Drugs Examples
Figure 5. Intramuscular Injection Examples
Figure 6. Others Examples
Figure 7. Global Musculoskeletal Pain Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Musculoskeletal Pain Treatment Consumption Value Market Share by Application in 2022
Figure 9. Clinic Examples
Figure 10. Hospital Examples
Figure 11. Others Examples
Figure 12. Global Musculoskeletal Pain Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Musculoskeletal Pain Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Musculoskeletal Pain Treatment Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Musculoskeletal Pain Treatment Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Musculoskeletal Pain Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Musculoskeletal Pain Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Musculoskeletal Pain Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Musculoskeletal Pain Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Musculoskeletal Pain Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Musculoskeletal Pain Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Musculoskeletal Pain Treatment Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Musculoskeletal Pain Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Musculoskeletal Pain Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Musculoskeletal Pain Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Musculoskeletal Pain Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Musculoskeletal Pain Treatment Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Musculoskeletal Pain Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Musculoskeletal Pain Treatment Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Musculoskeletal Pain Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Musculoskeletal Pain Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Musculoskeletal Pain Treatment Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Musculoskeletal Pain Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Musculoskeletal Pain Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Musculoskeletal Pain Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Musculoskeletal Pain Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Musculoskeletal Pain Treatment Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Musculoskeletal Pain Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Musculoskeletal Pain Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Musculoskeletal Pain Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Musculoskeletal Pain Treatment Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Musculoskeletal Pain Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Musculoskeletal Pain Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Musculoskeletal Pain Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Musculoskeletal Pain Treatment Consumption Value Market Share by Region (2018-2029)
Figure 54. China Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Musculoskeletal Pain Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Musculoskeletal Pain Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Musculoskeletal Pain Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Musculoskeletal Pain Treatment Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Musculoskeletal Pain Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Musculoskeletal Pain Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Musculoskeletal Pain Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Musculoskeletal Pain Treatment Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Musculoskeletal Pain Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Musculoskeletal Pain Treatment Market Drivers
Figure 75. Musculoskeletal Pain Treatment Market Restraints
Figure 76. Musculoskeletal Pain Treatment Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Musculoskeletal Pain Treatment in 2022
Figure 79. Manufacturing Process Analysis of Musculoskeletal Pain Treatment
Figure 80. Musculoskeletal Pain Treatment Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
